Avalon GloboCare director granted 200,000 stock options

Avalon GloboCare Corp. director Steven Andrew Sanders received a grant of 200,000 options to purchase common stock.

Rhea-AI Filing Summary

Avalon GloboCare Corp. director Steven Andrew Sanders received a grant of 200,000 options to purchase common stock. The options have an exercise price of $0.2820 per share and expire on June 29, 2029. According to the terms, all shares subject to the option vest in full on the grant date. Following this award, Sanders holds 202,132 derivative securities directly.

Filing Explained

The fully vested 200,000-share option creates conditional dilution exposure for existing holders through June 29, 2029.

This Form 4 reports that director Steven Andrew Sanders was granted a 200,000-share option on June 29, 2026, with all shares vesting on the grant date; code A identifies an award, not an exercise or issuance of common stock.

The option is exercisable from June 29, 2026 through June 29, 2029 at $0.282 per share, giving the director a conditional right to acquire 200,000 underlying common shares; the filing reports 202,132 derivative securities owned afterward.

For existing common holders, the structural effect is conditional potential dilution if the option is exercised, while this filing does not report that exercise has occurred or that common shares were issued.

The relevant follow-up is any exercise during the stated June 29, 2026 to June 29, 2029 window.

Insider Trade Summary

Grant/Award: 200,000 shares

Grant/Award 1 txn

Insider Sanders Steven Andrew

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Options (right to buy) F1	200,000	$0.00	$0.00

Holdings After Transaction: Options (right to buy) — 202,132 contracts (Direct)

Footnotes (1)

1. F1. One hundred percent (100%) of the shares subject to the Option shall vest in full on the grant date.

Key Figures

Options granted: 200,000 shares Exercise price: $0.2820 per share Expiration date: June 29, 2029 +2 more

5 metrics

Options granted 200,000 shares Options (right to buy) granted to director on June 29, 2026

Exercise price $0.2820 per share Conversion or exercise price of newly granted options

Expiration date June 29, 2029 Expiration of options (right to buy) granted to director

Post-transaction derivative holdings 202,132 Total derivative securities held directly after the grant

Vesting 100% on grant date All shares subject to the option vest in full immediately

Key Terms

Options (right to buy, Grant, award, or other acquisition, exercise price, vest in full on the grant date

4 terms

Options (right to buy financial

"security_title: Options (right to buy)"

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

exercise price financial

"conversion_or_exercise_price: 0.2820"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest in full on the grant date financial

"shares subject to the Option shall vest in full on the grant date"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Avalon GloboCare (ALBT) director Steven Andrew Sanders report on this Form 4?

He reported a grant of 200,000 stock options to buy Avalon GloboCare common stock. The award is compensation-related, classified as a grant, award, or other acquisition rather than an open-market purchase.

What is the exercise price of the options granted to the ALBT director?

The options have an exercise price of $0.2820 per share. This is the price at which Steven Andrew Sanders can purchase Avalon GloboCare common stock under this option award until the options expire.

When do the new Avalon GloboCare (ALBT) options granted to the director vest and expire?

All 200,000 option shares vest in full on the grant date. The options are scheduled to expire on June 29, 2029, providing a multi-year window during which they may be exercised.

How many Avalon GloboCare (ALBT) derivative securities does the director hold after this transaction?

After the option grant, Steven Andrew Sanders holds 202,132 derivative securities directly. This figure reflects his position in options or similar derivative instruments reported in this Form 4 filing.

Is the Avalon GloboCare (ALBT) Form 4 transaction an open-market buy or sell?

No. The filing reports a grant, award, or other acquisition of options, not an open-market buy or sell. The transaction code is A, indicating a compensation-related award of derivative securities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/13/2026 - 04:33 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sanders Steven Andrew

(Last) (First) (Middle)

C/O AVALON GLOBOCARE CORP.

4400 ROUTE 9, SUITE 3100

(Street)

FREEHOLD NEW JERSEY 07728

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Avalon GloboCare Corp. [ ALBT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options (right to buy)	$0.282	06/29/2026		A		200,000		06/29/2026(1)	06/29/2029	Common Stock	200,000	$0	202,132	D

Explanation of Responses:

1. One hundred percent (100%) of the shares subject to the Option shall vest in full on the grant date.

	/s/ Steven Andrew Sanders	07/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)